AOD 9604 Peptide: Full Description & Mechanism of Action

Name: AOD 9604 (5mg)
SKU: 80
Availability: InStock

What is AOD 9604?

AOD 9604 (Anti-Obesity Drug 9604) is a synthetic peptide fragment derived from human growth hormone (hGH), specifically corresponding to the C-terminal amino acid sequence 176–191. It was originally developed to isolate and replicate the fat-metabolizing (lipolytic) effects of growth hormone while avoiding its systemic and growth-related side effects.

Unlike full-length growth hormone, AOD 9604 is designed to selectively target fat metabolism without influencing processes such as tissue growth, insulin sensitivity, or IGF-1 production.

This selectivity has made it a subject of research in obesity, metabolic disorders, and body composition optimization.

Key Characteristics

Peptide Type: Modified hGH fragment (176–191)
Length: ~16–17 amino acids
Molecular Weight: ~1815 Da
Primary Function: Regulation of fat metabolism
Pharmacological Class: Lipolytic (fat-targeting) peptide

Mechanism of Action

AOD 9604 exerts its effects through a dual-action mechanism on adipose (fat) tissue, focusing on both fat breakdown and inhibition of new fat formation.

1. Stimulation of Lipolysis (Fat Breakdown)

AOD 9604 activates beta-3 adrenergic receptors located on adipocytes (fat cells). This activation triggers intracellular signaling pathways that:

Increase cyclic AMP (cAMP) levels
Activate hormone-sensitive lipase (HSL)
Promote breakdown of stored triglycerides into:
- Free fatty acids
- Glycerol

These byproducts are then released into circulation and utilized as energy.

2. Inhibition of Lipogenesis (Fat Formation)

Simultaneously, AOD 9604 suppresses the creation of new fat by inhibing key lipogenic enzymes, including:

Fatty acid synthase (FAS)
Acetyl-CoA carboxylase (ACC)

This reduces the conversion of excess nutrients into stored fat, effectively limiting fat accumulation.

3. Selective Pathway Activation (Non-GH Axis)

A defining feature of AOD 9604 is that it does not activate the classical growth hormone receptor pathway (JAK-STAT signaling). As a result:

No increase in IGF-1 (Insulin-like Growth Factor 1)
No stimulation of tissue growth
No significant impact on blood glucose or insulin sensitivity

This makes its activity metabolically selective, focusing primarily on fat regulation rather than systemic hormonal effects.

4. Direct Action on Adipose Tissue

Research suggests AOD 9604 acts directly on fat cells, enhancing:

Fat oxidation rates
Mobilization of stored fat (especially visceral fat)

This localized mechanism differentiates it from many systemic metabolic agents.

Summary of Mechanism

AOD 9604 works through a targeted fat-metabolism pathway characterized by:

✔ Increased fat breakdown (lipolysis)
✔ Reduced fat formation (lipogenesis)
✔ No activation of growth hormone systemic effects
✔ Minimal impact on glucose metabolism

This combination results in a focused modulation of adipose tissue metabolism without broader endocrine disruption.

Research & Regulatory Status

Studied in clinical trials for obesity and metabolic health
Development for weight loss showed limited clinical efficacy in large trials
Not approved as a pharmaceutical drug in most regions
Classified as research-use compound in many jurisdictions

Important Disclaimer

AOD 9604 is not FDA-approved for weight loss or general medical use. Most available data comes from preclinical studies and limited human trials, and its long-term safety and efficacy remain under investigation.

AOD 9604 Peptide

Targeted Fat Metabolism Support Without Systemic Hormonal Effects

Meta Title: AOD 9604 Peptide – Fat Loss Mechanism, Benefits & Research
Meta Description: Discover AOD 9604 peptide, a modified growth hormone fragment designed to support fat metabolism by increasing lipolysis and reducing fat formation. Learn how it works.

What is AOD 9604?

AOD 9604 is a synthetic peptide derived from the C-terminal fragment (176–191) of human growth hormone (hGH). It was specifically developed to isolate the fat-reducing properties of growth hormone without triggering its broader hormonal effects.

Unlike traditional hormone-based therapies, AOD 9604 is engineered to target fat metabolism directly, making it a unique compound in metabolic and obesity-related research.

How AOD 9604 Works (Mechanism of Action)

AOD 9604 operates through a dual-action mechanism focused on fat cells (adipocytes):

🔬 Stimulates Fat Breakdown (Lipolysis)

Activates beta-3 adrenergic receptors
Increases cyclic AMP (cAMP) levels
Enhances hormone-sensitive lipase (HSL) activity
Breaks down stored triglycerides into usable energy

🚫 Inhibits Fat Formation (Lipogenesis)

Suppresses key enzymes such as:
- Fatty acid synthase (FAS)
- Acetyl-CoA carboxylase (ACC)
Reduces conversion of excess calories into stored fat

⚖️ Selective, Non-Hormonal Pathway

Does not activate growth hormone receptors
Does not increase IGF-1 levels
Minimal impact on blood sugar and insulin

Result: A targeted approach to fat metabolism without systemic endocrine effects.

Key Benefits of AOD 9604

Supports fat metabolism and breakdown
Helps reduce stubborn adipose tissue
May assist in body composition optimization
Designed to avoid muscle growth or hormonal disruption
Minimal interaction with glucose metabolism

Why AOD 9604 is Different

Most fat-loss compounds influence hormones or the central nervous system. AOD 9604 stands apart because it:

Targets fat cells directly
Avoids growth hormone-related side effects
Focuses purely on metabolic pathways

This makes it especially appealing in research settings focused on obesity and metabolic health.

Scientific Background

AOD 9604 has been studied in both preclinical and clinical settings for its potential role in:

Obesity management
Fat metabolism regulation
Weight-related metabolic disorders

While early research demonstrated fat-reducing activity, large-scale human trials have shown mixed efficacy results, and further investigation is ongoing.

Safety & Regulatory Status

Not approved by the FDA for medical use
Commonly classified as a research-use compound
Long-term safety data in humans remains limited

Frequently Asked Questions

Is AOD 9604 a growth hormone?

No. It is a fragment of growth hormone that does not produce full hormone effects.

Does AOD 9604 affect muscle growth?

No. It is designed to avoid anabolic or growth-related activity.

Does it impact blood sugar levels?

Research suggests minimal effect on glucose metabolism, unlike full hGH.

Is AOD 9604 legal?

Its status varies by region, but it is typically sold for research purposes only.

Who is it For?

AOD 9604 is primarily of interest to:

Researchers studying fat metabolism
Professionals exploring obesity-related pathways
Individuals interested in non-hormonal metabolic compounds

Summary

AOD 9604 is a targeted peptide designed to enhance fat metabolism by stimulating lipolysis and inhibiting fat formation—without activating the broader hormonal effects of growth hormone.

Its selective mechanism of action makes it a compelling subject in metabolic research, though clinical outcomes remain under evaluation.

Disclaimer

This content is for educational and research purposes only. AOD 9604 is not approved for human use by regulatory authorities, and its safety and efficacy are still being studied.

AOD 9604 (5mg)

AOD 9604 Peptide: Full Description & Mechanism of Action

What is AOD 9604?

Key Characteristics

Mechanism of Action

1. Stimulation of Lipolysis (Fat Breakdown)

2. Inhibition of Lipogenesis (Fat Formation)